Bristol-Myers Squibb Company 13D and 13G filings for Acceleron Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-16 5:01 pm Purchase |
2020-07-01 | 13D | Acceleron Pharma Inc. XLRN |
BRISTOL MYERS SQUIBB CO BMY |
7,008,510 12.000% |
7,008,510 (New Position) |
Filing |